
Cosmos Pharmaceutical Corporation (PK) (CSMYF)
USOTC
Fin d'année 31 Mai 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | |
Return on Assets (%) | 8.506 | 7.404 | 7.32 | 7.219 | 8.209 | 6.575 | 6.071 | 5.449 |
Return on Equity (%) | 21.527 | 17.463 | 16.315 | 15.763 | 17.174 | 12.825 | 11.852 | 11.052 |
Return on Invested Capital (%) | 18.326 | 16.661 | 16.157 | 16.77 | 15.583 | 12.64 | 11.157 | 10.154 |
Operating Margin (%) | 5.139 | 4.526 | 4.453 | 4.452 | 5.321 | 4.382 | 3.966 | 3.504 |
Net Profit Margin (%) | 3.623 | 3.16 | 3.139 | 3.132 | 3.738 | 3.065 | 2.875 | 2.534 |
Book Value Per Share | 4641.9 | 5429.7 | 6300.1 | 7270.4 | 4256.194 | 4751.731 | 5262.993 | 5773.481 |
Earnings Per Share | 910.75 | 881.65 | 959.25 | 1071.75 | 678.883 | 578.861 | 594.91 | 611.335 |
Cash Per Share | 1386.4 | 1083.4 | 951.1 | 2606.1 | 1377.666 | 934.027 | 1148.171 | 1307.492 |
Working Capital Per Share | -2019.15 | -2418.15 | -2639.25 | -2390 | -860.278 | -1164.771 | -1374.166 | -1472.363 |
Operating Profit Per Share | 5052.3 | 5565.75 | 6139.2 | 6800.15 | 3652.284 | 3816.48 | 4257.494 | 4748.931 |
EBIT Per Share | 1286.85 | 1258.35 | 1356.95 | 1520.1 | 964.876 | 826.179 | 819.305 | 842.954 |
EBITDA Per Share | 1286.85 | 1258.35 | 1356.95 | 1520.1 | 964.876 | 826.179 | 819.305 | 842.954 |
Free Cash Flow Per Share | 1887.7 | 1848.95 | 1817.75 | 1799.85 | 1055.099 | 1367.666 | 1425.539 | 1627.309 |
Fin d'année 31 Mai 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 20M | 20M | 20M | 20M | 40M | 40M | 40M | 40M |
Capitalisation boursière | 1,82B |
Ratio cours/bénéfice | 0,07 |
Ratio prix/ventes | 0 |
Ratio prix/liquidités | 0,03 |
Ratio prix/valeur comptable | 0,01 |
Rendement de dividende | 26 052,97% |
Actions en circulation | 39,6M |
Volume moyen (1 semaine) | 0 |
Volume moyen (1 mois) | 0 |
Variation sur 52 semaines | -6,31% |
Plus haut sur 52 semaines | 51,06 |
Plus bas sur 52 semaines | 39,215 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales